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ABSTRACT
Objective: To compare the effectiveness and safety of
uterine artery occlusion by laparoscopy versus emboli-
zation as a treatment modality for symptomatic uterine
fibroids.
Methods: Ninety-six premenopausal women with symp-
tomatic uterine leiomyomata were studied. None of them
desired further pregnancy. They were randomized to
treatment either by laparoscopic occlusion (group 1) or by
radiologic embolization of uterine arteries (group 2). The
primary outcome measure was patient satisfaction as re-
gards menstrual blood loss compared with pretreatment
loss. Secondary outcome measures included postopera-
tive pain, complications, secondary interventions, and fail-
ures.
Results: Ninety women were followed for 1, 3, 6, and 12
months after both procedures. The primary outcome was
comparable between the 2 groups (86.7% after laparo-
scopic occlusion versus 88.8% after embolization, with no
statistically significant difference). After 12 months of fol-
low-up, more patients resumed heavy periods in the uter-
ine artery occlusion group [4/45 patients, 8.8% in occlu-
sion group compared with 3/45 (6.6%) in embolization
group, P0.044].
Conclusion: Both laparoscopic occlusion and superse-
lective embolization of uterine arteries improved clinical
symptoms in the majority of patients. At 12-month follow-
up, embolization might be more effective.
Key Words: Uterine myoma, Uterine artery occlusion,
Laparoscopy.
INTRODUCTION
Uterine leiomyomata, which occurs in one of every 4 to 5
women during reproductive life, is the most common
solid pelvic tumor in women.1 Menstrual abnormalities,
especially menorrhagia, which often leads to iron defi-
ciency anemia, are the most common complications of
uterine leiomyoma.1
Hysterectomy is the most common treatment for symp-
tomatic leiomyomata. Medical treatment combining
progestogen and hormonal therapy gonadotropin re-
leasing hormone agonists often meets with encouraging
but transient results in uterine leiomyomas.2 Surgical
procedures including myomectomy and hysterectomy
often are needed later during the course of events.3,4
But in addition to the risks associated with surgical proce-
dures, hysterectomy may be a cause of emotional trauma.5,6
For these reasons, the demand for alternative treatments
has increased during the last decade, both by patients and
by physicians looking for less invasive procedures. Uter-
ine leiomyoma embolization has become one such alter-
native procedure, and laparoscopic occlusion of uterine
vessels is suggested as another.
In a preliminary nonrandomized study,7 the authors re-
ported a reduction in menstrual bleeding and reduction of
leiomyoma volume after both uterine leiomyoma embo-
lization and laparoscopic occlusion of uterine vessels. In
the present randomized study, the clinical outcome of
these 2 methods is compared. The reduction in bleeding
after 6 months and 12 months, as measured by the pa-
tients’ own assessment, was the primary outcome vari-
able. Secondary outcome measures were the patients’
own assessment of pressure symptom reduction, postop-
erative pain, and nausea registration on visual analogue
scales, recovery time, complications, secondary interven-
tions, and failures.
MATERIALS AND METHODS
The study was performed in the Department of Obstet-
rics and Gynecology and the Department of Radiology,
Mansoura University Hospital. Ninety-six premeno-
pausal women referred to the university clinic for uterine
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SCIENTIFIC PAPERleiomyomas and menorrhagia or pressure symptoms be-
tween August 2006 and December 2008 were included in
this randomized, nonblinded trial. Inclusion criteria were
the women’s own interpretation of increased amounts of
bleeding, pressure symptoms, and an expressed desire
not to have a hysterectomy. Exclusion criteria were sus-
picion of malignancy, subserous leiomyomata that could
easily be removed by laparoscopic surgery, known ade-
nomyosis, and uterus size exceeding the umbilical level.
Submucous leiomyomata with a diameter of 3.5cm sit-
uated completely intracavitarily or with an intramural ex-
tension of 50% were considered more suitable for hys-
teroscopic resection and were therefore excluded. In
addition, women wishing to have children were excluded,
as were those with contraindications for surgery. All eli-
gible patients attended a consultation by a gynecologist,
which included a gynecological examination, ultrasonog-
raphy (the preoperative uterine evaluations were carried
out using ultrasound, which is the standard method for
evaluating myomas at our hospital). The patients were
informed about the possible risks and benefits of both
treatments. After agreeing to participate, patients signed a
written informed consent form before randomization took
place. Randomization of 1:1 was undertaken in a total of
10 blocks of 10 patients each, using sealed envelopes.
Five envelopes in each block of 10 were assigned to
laparoscopic treatment and 5 to uterine leiomyoma em-
bolization. The envelopes in each block were closed,
mixed, and then numbered. Treatment was decided by
drawing the next available envelope in ascending numer-
ical order.
Suction evacuation using a double valve IPAS syringe with
Carmen plastic cannula No. 6 was done for all patients to
exclude malignancy and small intracavitary lesions.
Interventional radiologists performed the embolization
procedure. The right femoral artery was punctured, and
the uterine arteries intubated with a 4F Cobra catheter or
a microcatheter. In all cases, both arteries were embolized
with 355- to 500-micron polyvinyl alcohol particles.
The laparoscopic bilateral occlusion of the uterine arteries
was carried out according to the standard technique es-
tablished by Semme.8 The uterine arteries and the anas-
tomotic sites between uterine and ovarian arteries were
occluded using clips or bipolar coagulation. The anterior
leaf of the broad ligament was opened with scissors, then
a Maryland clamp was used to dissect the broad ligament
towards its base. The roof of the ureteric canal was dis-
sected, and skeletonization of the uterine artery from the
ureter was carried out. The main stem of the uterine artery
was occluded using 2 clips (Figure 1) or using bipolar
coagulation. Cauterization of the anastomotic sites be-
tween uterine and ovarian arteries was then carried out
and the procedure repeated on the other side.
The participants were encouraged to use the same type of
sanitary pads during the study period. The study partici-
pants were surveyed in relation to their present leiomyo-
ma-related symptoms before treatment and after 1, 3, 6,
and 12 months, respectively.
A standardized questionnaire was used at all appoint-
ments. The amount of bleeding was rated as “little,” “mod-
erate,” “heavy,” or “very heavy.” Pressure symptoms, in-
cluding voiding problems, were recorded as “yes” or “no.”
Participants were asked to grade changes in amount of
bleeding and pressure symptoms as better, worse, or un-
changed. Total relief of symptoms at the 12-month fol-
low-up was defined as little or moderate bleeding and no
pressure symptoms. Clinical failure was defined as per-
sisting symptoms requiring secondary treatment or no
improvement at the 6-month follow-up. Postoperative
pain and nausea during the hospital stay were recorded
on postoperative charts. The resident doctors were
asked to fill in the level of pain and nausea patients
experienced every 4 hours during the first 24 hours in
the hospital and every 6 hours during the next 24 hours
or until the patient left the hospital. The analgesic regi-
men consisted of nonsteroidal anti-inflammatory drugs and
paracetamol-codeine combination in fixed doses.
Adverse events were also recorded for each patient during
the hospital stay and during outpatient visits after 1, 3, 6,
and 12 months. All subsequent surgical and medical in-
terventions, as well as readmission to the hospital or
Figure 1. Pain and nausea recorded in the first 48 hours after
treatment. SEMstandard error of the mean.
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events. Doppler study of uterine arteries was done 48
hours after the procedure for all participants.
Statistical analysis was performed with SPSS 12.0 (Chi-
cago, IL), and the data are presented as mean values for
normal distributed data and as median values for skewed
data. A 2-sided t test was used for comparisons of a
continuous variable in 2 patient groups if the variable in
question did not have a markedly skewed distribution. If
the distribution was markedly skewed, a 2-sided Wilcox-
on-Mann-Whitney test was used. A significance level of
0.05 was used for all tests. Power of the study and sample
size was acheived using PASS 2008 (Power analysis and
sample size, NCSS, Kaysville, UT, USA), we needed a
sample size of 90 patients, 45 in each group, achieving
98% power to detect a difference of -1.0, between the null
hypothesis that both group means were 0.0 and the alter-
native hypothesis that the mean of group 2 was 1.0, with
estimated group standard deviations of 1.0 and 1.0 and
with a significance level (alpha) of 0.05000 using a 2-sided
2-sample t test.9,10
RESULTS
Of the 96 patients randomized and included in the study,
90 patients received treatment, 45 with bilateral laparo-
scopic occlusion of uterine arteries (group 1) and 45 with
uterine artery embolization (group 2). All participants in
each group completed the 12-month trial. The 2 groups
were similar with respect to age, body mass index, parity,
and baseline symptoms.
The number of patients reporting reduced menstrual
bleeding, reduction of pressure symptoms, or total relief
of all symptoms after treatment did not differ significantly
between the 2 treatment groups (Table 1).
Clinical failure was seen in 5 (11.2%) subjects after uterine
leiomyoma embolization and in 6 (13.3%) subjects after
laparoscopic occlusion. There was no statistical difference
between the 2 groups (P0.13). However, there were
11/90 (12.2%) women still reporting heavy or very heavy
bleeding 6 months after treatment: 5/45 (11.1%) after uter-
ine leiomyoma embolization, and 6/45 (13.3%) after lapa-
roscopic treatment (Table 1). The difference in the inten-
tion-to-treat analysis with regard to the number of patients
who reported heavy bleeding was statistically insignificant
(P0.044). Four of these patients, 2 in the uterine leiomy-
oma embolization group and 2 in the laparoscopy group,
did not meet the definition of clinical failure. All 4 partic-
ipants reported improvement of symptoms, together with
reductions in their bleeding and received no additional
treatment during the study period. If these 4 participants
had been added to the group of patients deemed clinical
failures, there would have been 5 (11.2%) patients after
uterine leiomyoma embolization and 6 (13.3%) after lapa-
roscopy with unfavorable results 12 months after treat-
ment (P0.094).
Significantly more pain and nausea were observed after
uterine leiomyoma embolization than after laparoscopy.
The median amount of analgesic used after the emboliza-
tion procedure was 4 times higher than after laparoscopic
surgery: 46mg compared with 12mg (P0.001). No signif-
icant difference occurred in bleeding reduction between
the treatment groups 1 month after treatment (P0.96). At
1-month follow-up, the subjects treated by uterine artery
embolization had a mean bleeding assessment reduction
of 88.8%, as opposed to 86.7% for those treated with
laparoscopy. Also, at the 3-month follow-up, the subjects
treated with uterine artery embolization had a mean
bleeding assessment reduction of 88.9%, as opposed to
84.4% for those treated by laparoscopy (Table 2), while 6
months after uterine leiomyoma embolization, the reduc-
tion was still 88.9%, and the corresponding reduction for
laparoscopic treatment was 86.7% (Table 2). At 12-month
follow-up, the results were 91.9% versus 93.3% in group 1
and group 2, respectively (Table 2).
Only minor in-hospital adverse events were observed.
The patients were scheduled to stay for up to 48 hours in
the department after treatment.
Twenty-two patients noticed increased vaginal discharge
during the postoperative period, perhaps due to missed
submucosal or intrauterine tumors in those patients. No
significant differences were observed in the proportion of
Table 1.
Clinical Outcome at 1-Year Follow-up
LOUA (n45) UAE (n45) P
Bleeding Reduction 39 40 0.69
Reduction of Pressure
Symptoms
35 36 0.88
Total Relief of Pressure 33 35 0.15
All Symptoms
Completely Resolved
35 37 0.18
Satisfaction 36 39 0.23
Clinical Failure 6 5 0.13
aLOUA  laparoscopic occlusions of the uterine arteries; UAE 
uterine artery embolization.
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most serious adverse event, unilateral deep vein throm-
bosis, occurred in one patient who was readmitted to the
hospital 1 week after laparoscopic bilateral occlusion.
DISCUSSION
The primary goal of the present study was to compare the
improvement in bleeding patterns between uterine artery
embolization and laparoscopic occlusion. No significant
difference in symptom reduction was found between the
2 treatment options 12 months after treatment.
In the literature, one additional study11 reports using Pic-
torial Bleeding Assessment Chart reduction in 76 patients
treated by embolization and reported improvement in
55.6% after 3 months and 58.1% after 6 months, which is
significantly less than in our study.
The patients’ own assessment of symptom relief is more
commonly used as an outcome parameter than the Picto-
rial Bleeding Assessment Chart, even though there is a
lack of uniformity in defining the degree of improvement.
Notwithstanding these limitations, the present findings,
based on the patients’ own assessment 6 months after
uterine leiomyoma artery embolization, are similar to
those of other studies.2,3,5,6,11 The reduction of menstrual
bleeding symptoms in 93.3% and 91.9% of the patients,
after uterine leiomyoma embolization and laparoscopic
occlusion, respectively, in this study is in accordance with
the short-term results of the 2 largest prospective single-
center studies evaluating uterine leiomyoma embolization
to date, which reported improvements in menorrhagia in
89% of patients after 6 months and in 84% after 16 months,
respectively.6,11 Furthermore, the reduction in the amount
of bleeding in 91.9% of the patients after bilateral laparo-
scopic occlusion in this study is similar to that of other
studies that report improvement in these symptoms in
about 90% of the participants.
In contrast to the lack of difference between the 2 treat-
ment groups with regard to the percentage reduction in
patients’ own assessment of bleeding, significantly more
participants reported heavy or very heavy bleeding 6
months after laparoscopic treatment. One possible expla-
nation for this discrepancy might be differences in the
assessment of bleeding.
There are several possible explanations for the slightly
less favorable results after laparoscopic treatment. In the
literature, angiographic and surgical studies have shown
numerous anatomical variations of the uterine arteries.12,13
It is thus possible to occlude the wrong artery in laparos-
copy or to overlook one artery in cases where there are 2
instead of 1 single artery on one side. The reason for the
failure was found to be insufficient occlusion of the uter-
ine artery on one side.
The collateral arterial supply to the uterus in general could
explain smaller amounts of pain after surgical uterine
artery occlusion, in spite of ischemia and infarction of
leiomyomata. Because embolization is a more distal oc-
clusion reducing collateral flow, increased uterine isch-
emia can be expected, resulting in increased pain and
potentially increased efficacy compared with proximal
surgical occlusion. Concerns have been expressed among
interventional radiologists that leiomyomata that are not
completely infarcted will have the potential to regrow.13
In 2 prospective studies, 16%14 and 20%15 recurrence was
found 5 years to 7 years after embolization. If smaller
amounts of pain after laparoscopy were caused by less
ischemia and thus incomplete infarction of leiomyomata,
one would expect even more recurrences with time after
laparoscopic occlusion.
The proportion of patients requiring secondary surgery
was 5 (11.2%) in the UAE group and 6 (13.3%) in the
LOUA group in our study. This proportion is in accor-
dance with other reported outcomes after uterine leiomy-
Table 2.
Adverse Events After Treatment at 3-, 6-, and 12-Month Follow-up
LUAO UAE P
3m 6m 12m 3m 6m 12m
Menorrhagia 4 3 2 3 2 1 1.00
Metrorrhagia 3 3 2 2 3 2 1.00
Recurrent pressure symptoms 0 1 2 1 2 2 0.19
Total 7 7 6 6 7 5 0.12
aLOUA  laparoscopic occlusions of the uterine arteries; UAE  uterine artery embolization.
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studies, subsequent interventions or readmission occurred
in 10.5% after 21 months6 and in 7.5% after 17 months,11
respectively. In both of these studies, the main indica-
tions for secondary surgery were similar to those in this
study: continuous menorrhagia or symptoms related to
leiomyoma expulsion. Patient selection is probably
most significant for beneficial results, and more careful
selection might reduce the number of cases of second-
ary surgery caused by persistent menorrhagia or expul-
sion of leiomyomata.
Based on this study, both laparoscopic occlusion of the
uterine vessel and embolization appear to improve symp-
toms associated with uterine leiomyomata in the majority of
patients. The laparoscopic procedure resulted in less post-
operative pain and nausea and shorter hospital stays, al-
though significantly more participants experienced heavy
menstrual bleeding 6 months after laparoscopic occlusion,
indicating a more favorable effect after uterine leiomyoma
embolization. In light of these results and bearing in mind
the significant risk of surgical complications and lack of
long-term results, considering the fact that the laparoscopic
techniques are in the field of gynecologic surgery, laparo-
scopic uterine artery occlusion is likely to attract consider-
able interest as an effective alternative to hysterectomy treat-
ment of symptomatic uterine leiomyomata.
CONCLUSION
To perform successful laparoscopic uterine artery oc-
clusion, the surgeon has to be equipped with the nec-
essary laparoscopic skills and should be able to pre-
cisely locate the uterine artery to correctly ligate the
vessels. If these prerequisites are not met, massive
bleeding may ensure necessitating laparotomy; there-
fore, the laparoscopic procedure for leiomyoma treat-
ment should be confined to centers with appropriate
expertise in laparoscopic surgery.
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